MAPT and Cognitive impairment: Alzheimer’s disease is characterized by deposition of misfolded Aβ and tau proteins in the CNS parenchyma (Hardy and Selkoe, 2002), leading to BBB breakdown and cognitive impairment (Montagne et al., 2015; Jevtic et al., 2017).